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Abstract
Background: Patients with schizophrenia are known to have higher rates of mortality and morbidity when compared
to the general population. Suicidality is a major contributor to increased mortality. The International Suicide Prevention
Trial (InterSePT) Scale for Suicidal Thinking (ISST) is a validated tool to assess current suicidal ideation in patients with
schizophrenia. The aims of the study were to culturally adapt the Arabic translation of ISST and to examine the
psychometric characteristics of the Arabic version of the ISST among patients with schizophrenia in Qatar.
Methods: ISST was translated and adapted into formal Arabic using the back translation method. Patients diagnosed
with schizophrenia were randomly recruited from the department of Psychiatry, Rumailah Hospital, Doha, Qatar.
Healthy controls were randomly recruited from two primary health care centers in Doha, Qatar. The Arabic version of
Module B for suicidality in Mini International Neuropsychiatric Interview was used as the gold standard to which the
Arabic ISST was compared.
Results: The study sample (n = 199) was composed of 100 patients diagnosed with schizophrenia (age 35.30 ± 10.
04 years; M/F is 2/1) and 99 controls (age 33.98 ± 8.33 years; M/F is 2/3). The mean score on the ISST was 3.03 ± 4.75 vs.
0.47 ± 1.44 for the schizophrenia and control groups, respectively. Inter-rater reliability coefficient was 0.95, p > 0.001.
The overall Cronbach’s alpha was 0.92. Principal Component Analysis produced 3 factors explaining a total of 73.8% of
variance.
Conclusions: This is the first study in the Arab countries to validate the Arabic version of the ISST. The psychometric
properties indicate that the Arabic ISST is a valid tool to assess the severity of suicidal ideation in Arabic patients with
schizophrenia.
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Background
Schizophrenia is a chronic mental disorder characterized
by debilitating positive and negative symptoms [1, 2]. The
global burden of this disease can be conceptualized by a
lifetime prevalence rate of 1% [3], and an incidence rate of
15.2 (median value) per 100,000 persons per year [4]. Fur-
thermore, schizophrenia is associated with higher rates of
morbidity and mortality when compared to the general
population [5]. Hennekens et al. reported that patients
with schizophrenia have a decreased life expectancy by
20% [6], where at least 40% of this premature mortality
can be attributed to suicide and unnatural deaths [7].
A report by the National Association of State Mental
Health Program Directors showed that schizophrenia pa-
tients have a 25 year mortality gap when compared to the
general population [8]. About 30–40% of this premature
mortality is due to suicide and injury and 60% due to
medical reasons [8]. Palmer et al. reported a 4.9% lifetime
suicide risk among schizophrenia patients [9]. Meltzer and
Baldessarini showed that 9–13% of schizophrenia patients
lose their lives due to suicide [10]. They further indicate
that schizophrenia patients have a 0.2–0.3% annual suicide
rate [10]. There are no systematic studies on suicidal be-
haviors in patients with schizophrenia in the Arab coun-
tries, probably due to the lack of validated instruments. A
review on overall suicidality in the Arab countries by
Karam et al. reported a lifetime suicide attempt rate of
0.72–6.3% and a suicide ideation rate of 2.09–13.9%, in
the same population [11]. In the second part of the review,
which included a larger number of Arab countries, the au-
thors reported an annual suicide attempt rate of 1.9–127/
100,000 in the general Arab populations [12].
Preston and Hansen in a review of suicide rating scales
used in schizophrenia patients highlighted the import-
ance of prevention of suicide [13], a process that starts
by identifying the risk factors in the first place [14]. Such
factors include delusions, auditory hallucinations, and
poor treatment adherence [15]. Other studies point to-
wards drug misuse and alcohol abuse, whether current
or past [10, 16]. Depression [10, 17], history of suicide
[10, 18, 19], history of hospitalization to prevent suicide
[10], social isolation [18], and drug-induced parkinson-
ism [10] were reported by others as major risk factors in
determining the possibility of future suicide attempts.
Several instruments have been designed to assess sui-
cidality among mental health patients such as the Shee-
han Suicidality Track Scale (Sheehan-STS) [20], the
Beck Scale for Suicide Ideation (BSI) [21], the Positive
and Negative Suicide Ideation Inventory (PANSI) [22],
the Suicide Intent Scale (SIS) [23], the Columbia-Suicide
Severity Rating Scale (C-SSRS) [24], and the Schizophre-
nia Suicide Risk Scale (SSRS) [25]. The International
Suicide Prevention Trial (InterSePT) Scale for Suicidal
Thinking (ISST) is the only scale specifically designed to
assess current suicidal ideation among patients diag-
nosed with schizophrenia and schizoaffective disorder
[26]. The ISST was initially developed in a study that
assessed the effects of clozapine vs. olanzapine on pre-
venting suicide among high risk patients diagnosed with
schizophrenia and schizoaffective disorder [13, 27]. The
ISST is composed of 12 items, and examines suicidal
ideation along with its severity and related suicidal be-
havior [13]. The ISST takes approximately 20–30 min to
be completed by clinicians, and each item is rated on a
three level score system (0, 1, or 2) where the severity of
suicidal thinking increases with higher numbers [26].
Lindenmayer et al. assessed the reliability and validity of
the ISST among 1002 schizophrenia and schizoaffective
patients, of which 22 patients had recent suicide attempt.
The remaining sample (n = 980) had history of suicidal
ideation in the past 3 years. For patients with recent at-
tempts of suicide (n = 22), the results showed an intraclass
correlation coefficient of 0.90 for the total ISST score and
a mean weighted item kappa coefficients between 0.66–
0.92. As for those patients who had suicidal ideation in
the past 3 years (n = 980), the results showed a high in-
ternal consistency (Cronbach alpha = 0.86–0.89) for each
of the items on the scale, and a Cronbach alpha coefficient
of 0.88 for all items. The factor analysis on the ISST had
three factors explaining 55.2% of the variance. Addition-
ally, the results report a high correlation (p < 0.0001) be-
tween the Clinical Global Impression Scale-Severity (CGI-
S) and the total score of the ISST. The ISST total score
also significantly differentiated the various levels on the
Clinical Global Impression Scale for Severity of Suicidality
(CGI-SS) (p < 0.0001). The authors concluded that the
ISST is a reliable and valid scale that can be employed by
both researchers and clinicians, for suicidal risk assess-
ment among patients with schizophrenia and schizoaffec-
tive disorder [26].
Currently, there are no standardized suicidality as-
sessment scales in Arabic to assess suicide risk in
Arab patients with schizophrenia. The objectives of
this current study are to perform an Arabic translation
and cultural adaptation of the ISST, and to assess its
psychometric properties in terms of its validity, reli-
ability and factor structure among patients with
schizophrenia in Doha, Qatar.
Methods
This study is part of a project which involved the Arabic
translation, cultural adaptation and validation of several
scales adopted in the assessment and treatment of schizo-
phrenia, as the Positive and Negative Syndrome Scale
(PANSS), the Calgary Depression Scale for Schizophrenia
(CDSS), and ISST. The details reported here are those re-
lated mainly to the ISST.
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Translation and cross-cultural adaptation
A translation committee of three bilingual (English and
Arabic) psychiatrists and a professional translator was
formed. All psychiatrists have been practicing in Arab
countries for over ten years (one trained in United King-
dom, one in United States of America and one in Egypt).
These psychiatrists trained also the five raters who were in-
volved in the administration of the Arabic ISST. The raters
were supervised on at least five cases before they inter-
viewed the participants alone. All raters were also bilingual
(two physicians, two clinical psychologists and one nurse).
The committee members independently translated the Eng-
lish version of ISST to Arabic and after deliberation they all
approved one Arabic version of ISST. This version was first
piloted in a sample of 20 subjects (10 schizophrenia and 10
controls). These subjects were interviewed individually. The
most common theme was their reluctance to talk about
suicide especially when discussing the suicide desire and
the religious values. Most of the Arabs interviewed were
Muslims and accordingly suicide is a taboo and religiously
forbidden. This issue was addressed by training the raters
to better engage the subjects and facilitate the disclosure on
suicide. Few respondents commented that the Arabic trans-
lations of few words were not clear e.g “desire” (item 3),
“passive” (item 4), “deterrants” (item 8), “contemplate”
(items 9 and 10). These differences were attributed to the
variations in common dialect in different Arabic subcul-
tures. After the pilot phase, the psychiatrists and raters
underwent three focus group sessions to review the com-
ments and the raters’ experience with the pilot subjects.
The raters commented mainly on the religious deterrants
(item 8) and how this aspect might deter people from dis-
closing their thought about suicide. They also commented
that formal Arabic language needed additional clarifications
with the different Arabic subcultures. The raters added that
the training helped them to decide on the rating of each
item as there are no specific answers that can be given to
subjects to choose from. The comments of the participants
and raters in the pilot phase were reviewed again by the
committee and further changes were incorporated in the
second Arabic version that was sent for back translation by
a new professional translator. The committee reviewed the
back translation of the new professional translator and
made minor modifications that were culturaly and clinically
relevant. The final Arabic version, approved by all members
of the committee, and its back translation to English were
submitted then to the original author for revision. . The lat-
ter raised issues related to the back translation of few words
to make sue that the concepts in each item are covered
properly e.g item 1 (wish to die vs. desire to die), item 2
(reason vs. cause), item 4 (passive vs. inactive), item 10
(specificity vs. determination of method; considered vs.
taken into consideration). The author had few clarifications
and suggestions based on which the words were changed
(in Arabic and back translation) before his final approval.
The Arabic version of the corresponding approved back
translation was then used to be validated in the Arabic sub-
jects with schizophrenia.
Participants
All participants signed a written consent form before join-
ing the study. All study procedures and scales were
explained to participants before signing the written con-
sent. All study procedures complied with the most recent
Declaration of Helsinki. Approvals from the Institutional
Review Board (IRB) at Weill Cornell Medicine-Qatar
(WCM-Q) as well as the IRB at Hamad Medical Corpor-
ation (HMC) were obtained before the initiation of study
procedures. Patients diagnosed with schizophrenia (n =
100) were recruited from the Department of Psychiatry,
Rumailah Hospital, HMC, Doha, Qatar. Healthy controls
(n = 99) were recruited from two Primary Health Care
Centers (PHCC) in Doha, Qatar. The Department of
Psychiatry at Rumailah Hospital is the main psychiatric fa-
cility in Qatar. The ten outpatient clinics in the depart-
ment receive approximately 120 patients on daily basis.
The 4 inpatient wards have a 70 patient capacity, and are
usually at 90–95% occupancy rate, where the length of
stay is 2–4 weeks per patient. Medical records show that
approximately 25% of the outpatients fulfill the criteria for
the diagnosis of schizophrenia, while most of the inpa-
tients get admitted with acute psychotic symptoms. The
culture in Qatar is diverse with multiple ethnicities, lan-
guages, and traditions. Based on an official 2010 report,
Qataris and Arabs (non Qatari) represent 15 and 13% of
the population, respectively [28].
The inclusion criteria for patients with schizophrenia are:
(a) between 18–65 years of age (b) diagnosed with schizo-
phrenia as per the Diagnostic and Statistical Manual of
Mental Disorders IV (DSM IV) and confirmed by the Mini
International Neuropsychiatric Interview (MINI-6) Module
K for schizophrenia and other psychotic disorders (c) speak
Arabic as their first language (d) able to sign a consent form
(e) patients must not have any comorbid medical condi-
tions that could affect their ability to participate in the
study. The exclusion criteria for the schizophrenia group
are: (a) substance abuse over the last 6 months (b) impaired
hearing or speech (c) high risk to harm self or others (d)
presence of a psychiatric diagnosis based on DSM IV other
than schizophrenia with or without depression. The inclu-
sion and exclusion criteria for the controls are the same as
those of the schizophrenia patients except that control sub-
jects should not have schizophrenia or other psychiatric
disorders except for depression. All subjects enrolled
underwent a semi-structured interview to confirm the pres-
ence or absence of the diagnosis of schizophrenia (or other
psychiatric disorders) using MINI-6 for schizophrenia and
other psychotic disorders. The Arabic version of the MINI-
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6 has been previously used in several Arab countries to
screen for mental disorders [29, 30].
In regard to sample size, we believe that we satisfied the
condition of having at least 5 respondents per item [31] in
a scale even if we use the PANSS as a reference, which has
the largest number of items (30 questions) among the
scales used. Furthermore, others reported that having
about 200 subjects in a study to validate a scale is a fair
number [32]. The sample was recruited using random
sampling technique to try to give all the targeted subjects
an equal chance of being recruited to the study. All pa-
tients with schizophrenia and all attendees at PHCC were
randomly (every other patient) approached by their treat-
ment teams to be enrolled in the study and only the
eligible ones were selected if they accepted.
Research design
The Arabic Module B for suicidality in MINI-6 was used
as the gold standard to which the Arabic ISST was com-
pared. Two blinded raters were involved in the validation
process, the first administered the Arabic versions of the
MINI-6 (modules B and K) and the CDSS, while the sec-
ond administered the Arabic versions of the ISST and the
PANSS. Questionnaires were also developed to obtain
socio-demographic data and medical and psychiatric his-
tory. A total of 199 participants were recruited over a
period of 14 months (September 2013 – Dececember
2015), among those, 42 cases were assessed independently
by two raters for inter-rater reliability. These subjects were
selected randomly based on the approval of subjects and
the availability of two raters at the time of ISST assess-
ment with the aim of having at least 40 subjects enrolled
for this measure. The test-retest reliability was assessed
using 22 cases who accepted to return after three days to
be re-assessed by the same rater; the aim was to have at
least 20 subjects for this measure.
Statistical analysis
The Statistical Product and Service Solutions (SPSS) ver-
sion 22 was used to run the different statistical analyses.
Participants’ age and scores on the various instruments
were summarized using means and standard deviations and
were compared between the schizophrenia and control
group using the independent t-test. The rest of demo-
graphic variables such as gender, marital status, etc. were
summarized using frequency distributions and, whenever
available, compared between the schizophrenia and control
group using the Chi-squared test or Fisher’s exact test when
expected cell counts fell below 5. A linear regression was
carried out with the following sociodemographic variables
(age, gender, country born, marital status, education and
employment) along with the clinical characteristics (history
of suicide and history of aggression) to explore their rela-
tion with ISST total score for patients with schizophrenia.
Internal consistency was assessed using Cronbach alpha.
Inter-rater reliability was measured using the intraclass cor-
relation coefficient (ICC). Test-retest reliability was also
measured using the ICC along with the Pearson’s correl-
ation between the total scores at baseline and the second
measurement taken within 3 days. Correlation between
ISST and MINI-6 Suicidality Module B scores were tested
using Pearson’s correlation coefficient (r). Convergent valid-
ity was examined by comparing the ISST with item 8 on
suicidality in the CDSS, using Pearson’s correlation. Dis-
criminant validity was assessed by comparing the ISST to
the different levels on Module B (no, low, moderate, or high
risk of suicidality) of the MINI-6, using one-way analysis of
variance (ANOVA). In addition, the ability of ISST to differ-
entiate between patients’ with no or low suicide risk and
those with moderate to high suicidality based on Suicidality
Module B was assessed using Receiver Operating Charac-
teristic (ROC) curve. Principal Component Analysis (PCA)
with orthogonal rotation (varimax) was carried out to ex-
plore factor loadings, with a threshold of 0.50 [32]. Signifi-
cance level for all tests was set at 0.05.
Results
Descriptives
The control group was composed of 99 individuals (mean
age = 35.14 ± 10.08 years) (Table 1). The group of patients
with schizophrenia was composed of 100 individuals (mean
age = 33.96 ± 8.34 years). There were no age difference be-
tween the groups. However, there were significantly more
males in the schizophrenia group and more females in the
control group. The control group were more educated and
the majority were employed when compared to the patients
with schizophrenia (Table 1).
Patients with schizophrenia in this study reported hav-
ing history of aggression significantly more than control
subjects. In addition, none of the individuals in the con-
trol group reported having attempted suicide. In the pa-
tients with schizophrenia group, a total of 30.3% had a
history of suicide attempts where the number of at-
tempts ranged from 1–7 over the course of their illness.
The mean total scores on ISST, Module B, CDSS and
PANSS were significantly higher in patients with schizo-
phrenia compared to individuals in the control group
(Table 1). In the schizophrenia group, the mean age of
first psychiatric diagnosis was 23.64 ± 7.76 years, while
age of onset of symptoms was 22.88 ± 8.29 years. The
median number of hospitalizations was 3 (range 1–18).
Linear regression for the different sociodemographic
variables and clinical characteristics was significant, F
(8,78) = 3.939, p = 0.001. All the sociodemographic vari-
ables were not significant predictors of ISST total score.
However, having a history of suicide attempt or aggres-
sion did predict a higher score on ISST (p < 0.05).
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Reliability
The mean ISST score for schizophrenia patients in this
study was 3.03 ± 4.75, with items means ranging from 0.12
to 0.41. Overall Cronbach alpha was 0.92, which is consid-
ered as high level of internal reliability [33]. The latter
remained above 0.90 if any of the items were deleted from
the analysis; hence none of the items were dropped
(Table 2). The ICC for the inter-rater reliability including
active and control subjects (n = 42; n represents the
number of patients and healthy control cases that had the
ISST administered by two independent raters) ranged be-
tween 0.79 and 0.97 for the ISST items and was 0.96, p <
0.001 for the total ISST score (Table 3). Taking schizo-
phrenia group alone (n = 22) the ICC for the total ISST
score was 0.95, p < 0.001. According to Cicchetti, these
inter-rater reliabilities for the total ISST score are excellent
[34]. Test-retest reliability (n = 22 subjects with schizo-
phrenia; n represents the number of cases that had com-
pleted ISST twice within 3 days) was also high with ICC
of 0.93, p < 0.001 and r = 0.56, p < 0.001. Such measures
for the test-retest reliability are considered good [35].
Consruct validity: PCA
The PCA produced 3 factors explaining 55.83%, 9.33%,
and 8.64% percent of the variance (total 73.8%) respect-
ively [36]. Factor 1; labeled as current suicidal thinking, in-
cluded items # 1, 3, 7, 8, 9, 11, and 12. Loadings on this
factor ranged from 0.72–0.85 (Table 2). Factor 2; labeled
as passive suicidal ideation, included items 4, 5, and 6.
Loadings on this factor ranged from 0.76–0.83. Factor 3;
labeled as suicide contemplation, included items 2 and 10.
Loadings on this factor were 0.92 and 0.56, respectively.
Other validity measures
Concurrent validity
ISST total score significantly correlated with the scores on
MINI-6 Suicidality Module B, r = 0.62, p < 0.001 (Table 4).
Discriminant validity
The total Arabic ISST score differentiated between the dif-
ferent levels of suicidality according to module B. ANOVA
showed significant level effect, F (3, 193) = 39.52, p <
0.001. The difference according to Games Howell post
hoc test was significant between the level of no suicidality
based on module B and those belonging to the low and
high, p < 0.001 [37]. In addition, the ISST was also able to
differentiate between those with no or low suicide risk
and those with moderate to high suicidality based on
module B, with a sensitivity of 71.4% and a specificity of
81%. The area under the curve was good (0.81) indicating
that using the ISST score one can accurately classify 81%
of the patients into one of two groups (no/low vs. moder-
ate/high suicidality) (Fig. 1).
Convergent validity
The correlation of the total ISST score with the item on sui-
cidality in CDSS was significant, r = 0.67, p < 0.001. The
correlation of ISST total score with that of PANSS was also
significant but of lower magnitude (r = 0.43, p < 0.001).
Discussion
This study aimed at investigating the psychometric prop-
erties of the Arabic version of the ISST in a sample of
Table 1 Descriptive and clinical features of the patients with





N = 100 N = 99
Age (Mean ± SD) 35.14 ± 10.08 33.96 ± 8.34
Gender*
Male 67 (67%) 41 (41.4%)
Female 33 (33%) 58 (58.36%)
Country Born*
Qatari 62 (62%) 35(35.4%)
Non-Qatari 38 (38%) 64 (64.6%)
Marital Status
Married 16 (23.9%) 34 (82.9%)
Single 41 (61.2%) 7 (17.1%)
Divorced 9 (13.4%) 0 (0%)
Widowed 0 (0%) 0 (0%)
Missing 1 (1.5%) 0 (0%)
Education Level*
Never Attended School 2 (2%) 0 (0%)
Intermediate / Elementary 35 (35%) 8 (8.1%)
Secondary / High School 39 (39%) 16 (16.2%)
Vocational Degree 2 (2%) 15 (15.2%)
College / Post-Graduate University 22 (22%) 60 (60.6%)
Employment*
Employed / Student 40 (40%) 99 (100%)
Unemployed / Other 57 (57%) 0 (0%)
Retired 3 (3.0%) 0 (0%)
History of Aggression* 37 (37.0%) 2 (2.0%)
History of suicide attempts 30 (30%) 0 (0%)
Frequency of suicide attempts
(median/range)
2 (1–7) 0 (0%)
ISST total score(Mean ± SD) * 2.94 ± 4.64 0.47 ± 1.44
Module B total score * 5.54 ± 12.63 0.90 ± 4.99
PANSS total score (Mean ± SD) * 73.11 ± 23.10 31.59 ± 7.52
CDSS total score (Mean ± SD) * 4.28 ± 4.33 1.35 ± 2.70
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Arabic patients with schizophrenia and controls in
Doha, Qatar. The results showed that the Arabic version
of the ISST had satisfactory psychometric properties
with good reliability and validity measures. The Arabic
ISST score can also help to differentiate those with no or
low suicidality risk vs. those with moderate to high risk.
This is the first study to validate the Arabic ISST and as
it was done in formal Arabic, the official language in all
Arab countries, it can be widely used by all Arabs to as-
sess suicide in patients with schizophrenia. This study
have many strengths e.g the adoption of standard
methods for translation and cultural adaptation of scales,
the inclusion of a control group to confirm the specifi-
city of ISST for patients with schizophrenia, and the
training of the raters who were blind to the scores of the
gold standard.
Overall internal consistency was adequate (Cronbach
alpha = 0.92) and remained over 0.90 if any item was
dropped. This means that every item in the Arabic ISST is
well related to the total ISST score and that each one is








Mean SD Cronbach’s alpha
if item deleted
Q1. Wish to die 0.72 0.41 0.68 0.91
Q3. Desire to make active suicide attempt 0.84 0.24 0.54 0.91
Q7. Control over suicidal action/acting out/delusions/
hallucinations or self-harm
0.81 0.24 0.54 0.91
Q8. Deterrents to active attempt 0.74 0.25 0.59 0.91
Q9. Reasons for contemplating attempt 0.72 0.32 0.68 0.92
Q11. Expectancy/anticipation by patient of actual attempt 0.73 0.21 0.55 0.91
Q12. Delusions/hallucinations of self-harm 0.80 0.21 0.51 0.91
Q4. Passive suicidal desire 0.80 0.23 0.47 0.92
Q5. Frequency of suicidal ideation 0.83 0.20 0.45 0.92
Q6. Attitude towards ideation/wish 0.76 0.19 0.45 0.91
Q2. Reason for living vs dying 0.92 0.42 0.62 0.93
Q10. Method: Specificity/planning of contemplated attempt 0.56 0.12 0.33 0.92
Cronbach’s alpha 0.92 0.82 0.48
Eigenvalues 6.700 1.119 1.037
Percentage of Variance explained 55.83% 9.33% 8.64%
Kaiser-Mayer-Olkins Sampling of Adequacy KMO = 0.837. Barttlet’s test, χ2 (66) = 795.64, p < 0.001
Table 3 Intraclass correlation coefficient showing inter-rater reliability for each Arabic ISST item*
ICC* 95% CI
Wish to die 0.93 (0.88, 0.96)
Reason for living vs. dying 0.88 (0,78, 0.94)
Desire to make active suicide attempt 0.97 (0.94, 0.98)
Passive suicidal desire 0.80 (0.63, 0.89)
Frequency of suicidal ideation 0.92 (0.85, 0.96)
Attitude towards ideation/wish 0.90 (0.82, 0.95)
Control over suicidal action/acting out/delusions/ hallucinations or self-harm 0.86 (0.74, 0.92)
Deterrents to active attempt 0.84 (0.69, 0.91)
Reasons for contemplating attempt 0.97 (0.95, 0.99)
Method: Specificity/planning of contemplated attempt 0.79 (0.59, 0.89)
Expectancy/anticipation by patient of actual attempt 0.90 (0.82, 0.95)
Delusions/hallucinations of self-harm 0.97 (0.95, 0.99)
InterSePT Total Score 0.96 (0.92, 0.98)
CI Confidence Interval
*Sample size for inter-rater reliability was 42 (22 schizophrenia and 20 controls), p < 0.001
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contributing to the general construct of the scale. Inter-
rater reliability was good for the total ISST score (ICC =
0.96) and individual items. However, items 2 (reason for liv-
ing vs. dying), 4 (passive suicidal desire), 7 (control over
suicidal action/acting out/delusions/hallucinations or self-
harm), 8 (deterrents to active attempt), and 10 (method:
specificity/planning of contemplated attempt) had a lower
ICC (0.79–0.88). These lower values are probably related to
the variability in the raters’ ability to engage subjects and to
facilitate the disclosure about history of suicidal ideation
and attempts. The reliability measures of the Arabic ISST
are similar to those reported for the original English ISST
[26] and Polish version [38] in regard to internal
consistency and inter-rater reliability. This is the first study
to report on test retest reliability with ISST. The results of
the PCA (construct validity) produced also three compo-
nents as the English [26] and Polish ISST [38]. In the
Arabic ISST, the first factor involved suicidal thinking in
the current state, the second one covered passive suicidal
ideation, and the third factor involved suicide contempla-
tion. However, the validation study with the original ISST
revealed a total variance of 55.2% for the three factors,
which is less than the variance produced for the Arabic
ISST (73.3%). In addition, the loadings on each factor were
also different in the original ISST (36.4% factor 1: current
suicidal thinking; 9.4% factor 2: volitional suicidal thinking;
8.4% factor 3: cause of suicidal thinking). The first factor in
both studies involved current suicidal thinking and mutu-
ally included items # 1 and 3. The second factor mutually
included items # 4 and 6. While the third factor included
no mutual items. The differences in the factor structure in
both studies are probably due to several methodological
and cultural differences. For example, in the original
validation study the sample size was larger and all subjects
had schizophrenia with history of suicidal ideation or at-
tempts, while in our study many schizophrenia patients
had no such history. Furthermore, most of our subjects
were reluctant to elaborate on the history of suicidality for
religious reasons as presented above in relation to cross-
culural issues. The validation study of the Polish version of
the ISST reported that the PCA produced also three fac-
tors, which were reported to be congruent with those of
the English ISST [26]. However no details are available as
only an abstract [38] was published on the Polish version.
The total score of the Arabic ISST significantly correlated
with the score of the Arabic MINI-6 Suicidality Module B,
the only available Arabic gold standard to assess suicidality.
The score was also able to differentiate patients with no/
low suicidality risk from those with moderate/high risk with
Table 4 Concurrent, discriminant and convergent validity measures of the Arabic ISST
Statistical test 95% CI p-value
Concurrent Validity: ISST total score with Module B total score Pearson’s Correlation 0.64 (0.43, 0.78) p < 0.001
Discriminant Validity:
ISST total score with Module B suicidality risk: ANOVA
None (reference group) EMM 0.59 (0.12, 1.05)
Low EMM 2.71 (1.85, 3.57) P = 0.004a
Moderate EMM 6.57 (4.50, 8.65) P = 0.28
High EMM 9.67 (7.83, 1.50) P = 0.01a
Convergent Validity:
ISST total score with CDSS total score Pearson’s Correlation 0.61 (0.42, 0.73) p < 0.001
ISST total score with PANSS total score Pearson’s Correlation 0.43 (0.29, 0.57) p < 0.001
aCompared to the reference group with no suicidality. EMM: Estimated Marginal Mean of ISST total score. Sample used in the validity tests includes both groups,
schizophrenia and control groups and the sample size is 199
Fig. 1 Receiver operating characteristic (ROC) curve for the total ISST
scores obtained from the schizophrenia group (N = 100) normalized to
the total score on MINI-6 Module B that was used to separate patients
with no or low risk vs. those with moderate to high suicidality risk. Area
under the ROC curve (AUC) is 0.808 with 95% CI (0.669–0.948)
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adequate sensitivity and specificity. Similar to the results of
the English ISST [26], the convergent validity of the Arabic
ISST was also significant when the total score on the ISST
was compared to the item on suicidality in the Arabic
CDSS and the total score of the Arabic PANSS. Ayer et al.
examined the ability of the ISST to predict attempts or hos-
pitalizations to prevent attempts of suicide in a study that
compared the ISST to the results of the CDSS. The study
concluded that higher numbers on both scales might be a
useful indication as to when preventive measures need to
be considered [39].
The design of this study have several strengths that
were presented above, however there are few limitations
that are worth discussing. First, module B inquires about
suicidality over the past month, while ISST covers the
suicidal ideation in the past week. This would possibly
produce some variability that will not be assessed by the
different validity measures. However, the two scales sig-
nificantly correlated in our study. Second, ISST is specif-
ically designed for schizophrenia patients while MINI-6
Module B is a tool to assess suicide in general, and thus
the latter might not capture the command hallucinations
and their delusional interpretation on the risk of suicide
in patients with schizophrenia. However, the two Arabic
tools correlated significantly in this study. Third, the
sample had more males and there might a gender that
limits the generalizability of the results. This gender bias
is probably due to the nature of the disease being more
severe among males and many of the schizophrenia pa-
tients were recruited from the inpatient wards. Another
contributing factor to this bias is the population distri-
bution in the country being skewed towards males where
the male/female ratio is 3 [28]. Finally, both scales use
formal Arabic which is the official language in all Arab
countries but it is not the common dialect that is used
daily by most Arab people; and thus its understanding
might be confounded by the socioeconomic status and
level of education of the Arab participants enrolled in
this study.
Conclusions
This study provides a culturally adapted and scientifically
validated Arabic ISST that can be used in the assessment
of suicidality among Arab speaking patients with schizo-
phrenia. However, larger studies are needed to include
more Arab people from the various Arabic cultures to
check for possible confounding factors like nationality and
level of education, and to check if our findings are
generalizable to all Arab countries.
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